| Nondestructive tissue analysis for ex vivo and in vivo cancer diagnosis using a handheld mass spectrometry system J Zhang, J Rector, JQ Lin, JH Young, M Sans, N Katta, N Giese, W Yu, ... Science translational medicine 9 (406), eaan3968, 2017 | 471 | 2017 |
| Antibody-based imaging strategies for cancer JM Warram, E De Boer, AG Sorace, TK Chung, H Kim, RG Pleijhuis, ... Cancer and Metastasis Reviews 33 (2), 809-822, 2014 | 161 | 2014 |
| A triple‐targeted ultrasound contrast agent provides improved localization to tumor vasculature JM Warram, AG Sorace, R Saini, HR Umphrey, KR Zinn, K Hoyt Journal of Ultrasound in Medicine 30 (7), 921-931, 2011 | 125 | 2011 |
| Microbubble-mediated ultrasonic techniques for improved chemotherapeutic delivery in cancer AG Sorace, JM Warram, H Umphrey, K Hoyt Journal of drug targeting 20 (1), 43-54, 2012 | 114 | 2012 |
| Quantitative mapping of tumor vascularity using volumetric contrast-enhanced ultrasound K Hoyt, A Sorace, R Saini Investigative radiology 47 (3), 167-174, 2012 | 99 | 2012 |
| Microbubble therapy enhances anti-tumor properties of cisplatin and cetuximab in vitro and in vivo CH Heath, A Sorace, J Knowles, E Rosenthal, K Hoyt Otolaryngology--Head and Neck Surgery 146 (6), 938-945, 2012 | 97 | 2012 |
| Ultrasonics, Ferroelectrics and Frequency Control J Vig, Y Kim IEEE Transactions on 46, 1558, 1999 | 76* | 1999 |
| Molecular ultrasound imaging using a targeted contrast agent for assessing early tumor response to antiangiogenic therapy AG Sorace, R Saini, M Mahoney, K Hoyt Journal of Ultrasound in Medicine 31 (10), 1543-1550, 2012 | 72 | 2012 |
| Repeatability, reproducibility, and accuracy of quantitative mri of the breast in the community radiology setting AG Sorace, C Wu, SL Barnes, AM Jarrett, S Avery, D Patt, B Goodgame, ... Journal of Magnetic Resonance Imaging 48 (3), 695-707, 2018 | 67 | 2018 |
| Volumetric contrast‐enhanced ultrasound imaging of renal perfusion M Mahoney, A Sorace, J Warram, S Samuel, K Hoyt Journal of Ultrasound in Medicine 33 (8), 1427-1437, 2014 | 66 | 2014 |
| Evaluating patient-specific neoadjuvant regimens for breast cancer via a mathematical model constrained by quantitative magnetic resonance imaging data AM Jarrett, DA Hormuth II, C Wu, AS Kazerouni, DA Ekrut, J Virostko, ... Neoplasia 22 (12), 820-830, 2020 | 63 | 2020 |
| Experimentally-driven mathematical modeling to improve combination targeted and cytotoxic therapy for HER2+ breast cancer AM Jarrett, A Shah, MJ Bloom, MT McKenna, DA Hormuth, TE Yankeelov, ... Scientific reports 9 (1), 12830, 2019 | 59 | 2019 |
| Imaging for response assessment in cancer clinical trials AG Sorace, AA Elkassem, SJ Galgano, SE Lapi, BM Larimer, ... Seminars in nuclear medicine 50 (6), 488-504, 2020 | 58 | 2020 |
| Multiparametric analysis of longitudinal quantitative MRI data to identify distinct tumor habitats in preclinical models of breast cancer AK Syed, JG Whisenant, SL Barnes, AG Sorace, TE Yankeelov Cancers 12 (6), 1682, 2020 | 58 | 2020 |
| CCR7 modulates the generation of thymic regulatory T cells by altering the composition of the thymic dendritic cell compartment Z Hu, Y Li, A Van Nieuwenhuijze, HJ Selden, AM Jarrett, AG Sorace, ... Cell reports 21 (1), 168-180, 2017 | 58 | 2017 |
| Correlation of tumor characteristics derived from DCE‐MRI and DW‐MRI with histology in murine models of breast cancer SL Barnes, AG Sorace, ME Loveless, JG Whisenant, TE Yankeelov NMR in Biomedicine 28 (10), 1345-1356, 2015 | 55 | 2015 |
| Distinguishing benign and malignant breast tumors: preliminary comparison of kinetic modeling approaches using multi-institutional dynamic contrast-enhanced MRI data from the … AG Sorace, SC Partridge, X Li, J Virostko, SL Barnes, DS Hippe, W Huang, ... Journal of Medical Imaging 5 (1), 011019-011019, 2018 | 54 | 2018 |
| Quantifying tumor heterogeneity via MRI habitats to characterize microenvironmental alterations in HER2+ breast cancer AS Kazerouni, DA Hormuth, T Davis, MJ Bloom, S Mounho, G Rahman, ... Cancers 14 (7), 1837, 2022 | 52 | 2022 |
| Trastuzumab improves tumor perfusion and vascular delivery of cytotoxic therapy in a murine model of HER2+ breast cancer: preliminary results AG Sorace, CC Quarles, JG Whisenant, AB Hanker, JO McIntyre, ... Breast cancer research and treatment 155 (2), 273-284, 2016 | 52 | 2016 |
| 18F-FMISO PET Imaging Identifies Hypoxia and Immunosuppressive Tumor Microenvironments and Guides Targeted Evofosfamide Therapy in Tumors Refractory … KM Reeves, PN Song, A Angermeier, DD Manna, Y Li, J Wang, ES Yang, ... Clinical Cancer Research 28 (2), 327-337, 2022 | 50 | 2022 |
